Some Interesting M&A Data Uncovered by Mergermarket
- Global Pharma, Medical & Biotech deals have already surpassed every full Q1 since 2009’s peak. Deals value are nearly four times above last year’s.
- In Europe, total deal value already in Q1 is 44.6% above Q1 2013 and the highest since 2010’s opening quarter.
- In the US, a busy February 17th week of mega-deals: the USD 24.2bn acquisition of Forest Laboratories by Actavis propelled the opening quarter’s deal value over thirteen times above Q1 2013. As a result, Q1 2014 is already the highest values opening quarter since the peak Q1 in 2009.
Photo: radialinfo.com